Latest Market News

Avira Resources has secured a binding agreement to acquire the high-grade Mt Cattlin Gold Project in Western Australia, backed by a $2.5 million capital raise to advance exploration and resource development.

Flynn Gold Limited has reported significant progress in its Tasmanian gold exploration projects, including new high-grade gold discoveries and a successful $5 million capital raise to fund further drilling and development.

Southern Palladium has raised A$20 million through a strategic share placement to accelerate its Bengwenyama PGM project, positioning the company for key milestones including a Final Investment Decision in 2026.

BMG Resources has addressed recent unusual trading activity, confirming no undisclosed material information and providing an update on its Bullabulling drilling program results.

Audio Pixels Holdings has extended the maturity of $12.3 million in convertible notes to January 2027 and capitalised $4.05 million in accrued interest, enhancing its financial flexibility.

Arika Resources has agreed to sell its Admiral Bay Zinc Project for $1.15 million upfront, unlocking capital to accelerate drilling at its promising gold projects in Western Australia.

Jindalee Lithium has launched an options offer linked to its recent Share Purchase Plan and placements, aiming to incentivize shareholders and raise capital for its lithium development projects. The options carry an exercise price of $0.825 and expire in late 2028.

Jindalee Lithium has successfully raised $8 million through a private placement, complemented by a $1 million Share Purchase Plan, to advance its McDermitt Lithium Project and a strategic US SPAC transaction.

European Lithium Limited has launched a replacement options offer for holders of 205 million expiring options, with directors committing to fully participate and underwrite the offer pending shareholder approval at the upcoming AGM.

BCAL Diagnostics has launched a $10 million convertible note facility, with $5 million already committed, to strengthen its capital position and accelerate commercialisation of its cancer detection technologies.

Scout Security has raised a further $220,000 through a share placement, bringing total capital raised to $820,000, as it works toward resolving its trading suspension.

Mesoblast Limited reports a 69% jump in net revenues from its pioneering cell therapy Ryoncil in Q1 FY2026, propelled by expanded physician adoption and new reimbursement pathways. The company also secures convertible note funding and plans pivotal adult trials.